The first participant in the trial has already received a dose of the omicron-specific booster shot, according to Moderna.
The first participant in the trial has already received a dose of the omicron-specific booster shot, according to the company.The first group will include people who received the two-dose vaccine, and the second group will include people who received the two-dose vaccine and the current booster.
The first participant in the phase two trial has already received a dose of the omicron-specific booster shot, according to the company. The neutralizing antibodies triggered by Moderna's existing booster declined faster when pitted against omicron, 6.3 fold, compared with a decline of about 2.3 fold against the original strain of the virus over the same time period.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Covid-19 news: Strain on health services led to extra non-covid deathsToday’s covid-19 news: · 4000 excess non-covid 19 deaths occurred in England during first year of pandemic · Acute phase of pandemic could end in 2022 with improved vaccination rates, says WHO · Israel recommends fourth vaccine dose for all adults
Baca lebih lajut »
Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots - studyA third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels significantly in those who have previously received two doses of Sinovac's CoronaVac shot, a study has found.
Baca lebih lajut »
Sarah Palin allegedly flouted COVID rules by dining indoors unvaccinated ahead of trialA Manhattan restaurant is looking into its enforcement of vaccine requirements for indoor dining after Sarah Palin allegedly dined there indoors while unvaccinated.
Baca lebih lajut »
Sarah Palin COVID-19 tests delay libel trial against NY TimesSarah Palin tested positive for COVID-19 Monday, forcing a postponement of the start of a trial in her libel lawsuit against The New York Times.
Baca lebih lajut »
Pfizer starts clinical trial for omicron-specific Covid vaccineJUST IN: Pfizer and BioNTech announce that they have started a clinical trial testing a modified Covid-19 vaccine to protect against the omicron variant.
Baca lebih lajut »
Pfizer Begins Clinical Trial for Omicron-Specific COVID VaccinePfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant
Baca lebih lajut »